Medsource Ozone Biomedicals Pvt. Ltd.

Based in Haryana, India, and founded in 2003, Medsource Ozone Biomedicals Pvt. Ltd. operates as a manufacturer of clinical diagnostic products for emerging markets in Asia, Africa, and South America. In January 2022, Medsource Ozone Biomedicals Pvt.

Ltd. raised series A funding from new investor Xponentia Capital Partners. The company's line of products include testing instruments, rapid test kits, COVID RT-PCR related kits and reagents for conducting several kinds of diagnostic tests by laboratories. The company also has a D2C brand Ozocheck where it sells personal use medical devices through online and offline channels.

The company provides products services including biochemistry analyzers, reagents and controls/calibrators, coagulation analyzers and reagents, hematology analyzers and controls/calibrators, real time pcr systems and pcr assays, nucleic acid extraction, fluorescence microscopy, immunofluorescence assays, line immunoassays, autoimmune elisa kits, automated workstations and tests for infectious diseases, sexually transmitted diseases, fertility, cardiac markers, sepsis, rheumatology and urinalysis. The funding will support the company's growth towards its customers, team members, shareholders, and patients. The company plans to grow through acquisitions and partnerships in adjacent product segments.